[Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products].
This article presents the French national recommendations for the use of blood products in medicine.
Gouëzec
H
H
Unité de sécurité transfusionnelle et d'hémovigilance, CHU de Rennes, Pontchaillou, France. herve.gouezec@chu-rennes.fr
Jego
P
P
Bétrémieux
Pierre
P
Nimubona
Stanislas
S
Grulois
Isabelle
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D001688:Biological Products / Q000627:therapeutic use*; D016913:Blood Component Transfusion; D001789:Blood Group Antigens / Q000276:immunology; D001787:Blood Group Incompatibility; D001803:Blood Transfusion; D001810:Blood Volume; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D020896:Hypovolemia / Q000628:therapy; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged
D001688:Biological Products; D001789:Blood Group Antigens